[Federal Register Volume 89, Number 4 (Friday, January 5, 2024)]
[Notices]
[Pages 791-792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-29020]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on

[[Page 792]]

how to prevent or reduce the burden of Alzheimer's disease and related 
dementias (ADRD) on people with the disease and their caregivers. 
During the meeting on January 22, 2024, the Advisory Council will hear 
updates from the field on implementation of disease-modifying therapies 
for Alzheimer's disease and outstanding research questions. A panel 
will present on the latest research on diagnosis and development of 
treatments for other populations and causes of dementia.

DATES: The meeting will be January 22, 2024 from 9:30 p.m. to 4:30 p.m. 
EST.

ADDRESSES: The meeting will be a hybrid of in-person and virtual. The 
meeting will be held in Room 800 of the Hubert H. Humphrey Building, 
200 Independence Avenue SW, Washington, DC 20201. It will also stream 
live at www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited 
to two (2) minutes per individual. In order to provide a public 
comment, please register by emailing your name to [email protected] by 
Wednesday, January 17. Registered commenters will receive both a dial-
in number and a link to join the meeting virtually; individuals will 
have the choice to either join virtually via the link, or to call in 
only by using the dial-in number. Note: There may be a 30-45 second 
delay in the livestream video presentation of the conference. For this 
reason, if you have pre-registered to submit a public comment, it is 
important to connect to the meeting by 3:45 p.m. to ensure that you do 
not miss your name and allotted time when called. If you miss your name 
and allotted time to speak, you may not be able to make your public 
comment. Public commenters will not be admitted to the virtual meeting 
before 3:30 p.m. but are encouraged to watch the meeting at 
www.hhs.gov/live. Should you have questions during the session, please 
email [email protected] and someone will respond to your message as quickly 
as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Tuesday, January 
23, 2024. These comments will be shared on the website and reflected in 
the meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Tuesday, January 23, 2024 to Helen Lamont, Ph.D., 
OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. 
Comments may also be sent to [email protected]. Those submitting written 
comments should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: subcommittee recommendations, NIA 
bypass budget, FDA drug coverage decisions, and CDC Health Brain 
Initiative.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available after the meeting. This meeting is 
open to the public. Please allow 30 minutes to go through security and 
walk to the meeting room. Participants joining in person should note 
that seating may be limited. Those wishing to attend the meeting in 
person must send an email to [email protected] and put ``January 22 Meeting 
Attendance'' in the subject line by Wednesday, January 17 so that their 
names may be put on a list of expected attendees and forwarded to the 
security officers at the Department of Health and Human Services. Any 
interested member of the public who is a non-U.S. citizen should 
include this information at the time of registration to ensure that the 
appropriate security procedure to gain entry to the building is carried 
out. Although the meeting is open to the public, procedures governing 
security and the entrance to Federal buildings may change without 
notice. If you wish to make a public comment, you must note that within 
your email.
    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: December 22, 2023.
Miranda Lynch-Smith,
Deputy Assistant Secretary for Human Services Policy, Performing the 
Delegable Duties of the Assistant Secretary for Planning and 
Evaluation.
[FR Doc. 2023-29020 Filed 1-4-24; 8:45 am]
BILLING CODE 4150-05-P